|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 10794938.0 (espacenet) (Federated) (European Patent Register), 20101208 | | Patent/reg. no. and date | DK/EP 2510001, 20151202 | | Publication date | 20121017 | | Priority no. and date | US 267446 P, 20091208 | | EP pub. no. and date |
EP 2510001 20121017 | | Effective date | | | Applicant/owner | AbbVie Deutschland GmbH & Co KG, Max-Planck-Ring 2a
65205 Wiesbaden, DE | | Applicant ref. no. | P017596EPDK1 | | Inventor | MÜLLER, Bernhard, K., Altbachstr. 10A
67435 Neustadt, DE | | Representative | CHAS. HUDE A/S, Langebrogade 3B, 1411 København K, DK | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , C07K 16/22 (2006.01) | | Title | MONOKLONALE ANTISTOFFER MOD RGM A-PROTEINET TIL ANVENDELSE TIL BEHANDLING AF DEGENERATION AF DET RETINALE NERVEFIBERLAG | | Int. application no. | EP2010069120 | | Int. publication no. | WO2011070045 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
